CD34 IMMUNOHISTOCHEMICAL ASSESSMENT OF ANGIOGENESIS AS A PROGNOSTIC MARKER FOR PROSTATE CANCER RECURRENCE AFTER RADICAL PROSTATECTOMY-Reference-Cited by-同舟云学术

CD34 IMMUNOHISTOCHEMICAL ASSESSMENT OF ANGIOGENESIS AS A PROGNOSTIC MARKER FOR PROSTATE CANCER RECURRENCE AFTER RADICAL PROSTATECTOMY

Published:1998-08 Issue:2 Volume:160 Page:459-465
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

BETTENCOURT MARIE-CLAUDE¹,BAUER JOHN J.¹,SESTERHENN ISABELLA A.¹,CONNELLY ROGER R.¹,MOUL JUDD W.¹

Affiliation:

1. Urology Service, Department of Surgery, Walter Reed Army Medical Center and Department of Genitourinary Pathology, Armed Forces Institute of Pathology, Washington, D. C., and Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, Maryland

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference32 articles.

1. Cancer statistics, 1997;Parker;CA,1997

2. What is the evidence that tumors are angiogenesis-dependent?;Folkman;J. Natl. Cancer Inst.,1990

3. Tumor angiogenesis: therapeutic implications;Folkman;New Engl. J. Med.,1971

4. Angiogenesis and breast cancer;Folkman;J. Clin. Oncol.,1994

5. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens-evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willibrand factor;Miettinen;Mod. Path.,1994

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of prostate cancer associated genes for diagnosis and prognosis: a modernized in silico approach;Mammalian Genome;2024-08-17

2. Different predictive values of microvessel density for biochemical recurrence among different PCa populations: A systematic review and meta‐analysis;Cancer Medicine;2022-08-07

3. The relationship between prostatic microvessel density and different concentrations of oestrogen/androgen in Sprague-Dawley rats;European Journal of Medical Research;2022-06-07

4. PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial;Nature Medicine;2022-03-21

5. Angiogenic Index as a Measure of Angiogenesis in Prostate Cancer and Its Correlation with Gleason Grade and Score;JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH;2022